Tue 22 Sep 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Strength | Doesage Form | Price | Details |
|---|---|---|---|---|---|
| BREXPIPRAZOLE | Zolabri | 1 | Film-coated tablet | 308.60 | Details |
| BREXPIPRAZOLE | Zolabri | 0.5 | Film-coated tablet | 136.35 | Details |
| BREXPIPRAZOLE | Zolabri | 0.25 | Film-coated tablet | 83.10 | Details |
| BREXPIPRAZOLE | Zolabri | 4 | Film-coated tablet | 58.15 | Details |
| DOXYLAMINE SUCCINATE,PYRIDOXINE | Xonvea | 20,20 | Prolonged-release tablet | 218.20 | Details |
| Lazertinib | Lazcluze | 240 | Film-coated tablet | 28729.50 | Details |
| Lazertinib | Lazcluze | 80 | Film-coated tablet | 28729.50 | Details |
| POLATUZUMAB VEDOTIN | Polivy | 30 | Powder for concentrate for solution for infusion | 9280.80 | Details |
| DAPOXETINE | TALYNTA | 60 | Film-coated tablet | 98.00 | Details |
| DAPOXETINE | TALYNTA | 30 | Film-coated tablet | 98.00 | Details |
| LORATADINE | TIDILOR | 10 | Tablet | 40.75 | Details |
| TADALAFIL | Helt | 20 | Film-coated tablet | 190.35 | Details |
| TADALAFIL | Glofel | 20 | Film-coated tablet | 16 | Details |
| KETAMINE | Tekam | 50 | Solution for injection/infusion | 265.50 | Details |
| OMEPRAZOLE | Omisec | 40 | Powder for solution for infusion | 78.75 | Details |
| CHLORPHENIRAMINE MALEATE | Zistan | 4 | Tablet | 56.60 | Details |
| CHOLECALCIFEROL | Veggie Vitamin D3 | 10000 | Capsule, soft | 38.45 | Details |
| OLMESARTAN MEDOXOMIL,AMLODIPINE BESILATE,HYDROCHLOROTHIAZIDE | Olmidip HCT | 20,5,12.5 | Film-coated tablet | 52.10 | Details |
| OLMESARTAN MEDOXOMIL,AMLODIPINE BESILATE,HYDROCHLOROTHIAZIDE | Olmidip HCT | 40,5,12.5 | Film-coated tablet | 66.75 | Details |
| OLMESARTAN MEDOXOMIL,AMLODIPINE BESILATE,HYDROCHLOROTHIAZIDE | Olmidip HCT | 40,5,25 | Film-coated tablet | 66.75 | Details |
5.56% of users said yes from 270 Response.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.